COVID-19疫情期间局部晚期直肠癌管理:MSKCC的必要范式转变
本文介绍Memorial Sloan Kettering Cancer Center在COVID-19疫情期间对局部晚期直肠癌实践政策的快速重新评估。疫情前常用全程新辅助治疗且强烈偏好长程放化疗,疫情期间则强制采用短程放疗。作者认为尽管多项随机试验显示短程放疗与长程放化疗在局部复发、远处复发或总生存上无差异,但美国采用短程放疗的比例一直较低,疫情下需重新评估相关顾虑。
要点
- 疫情前MSKCC常用全程新辅助治疗并强烈偏好长程放化疗。
- 疫情期间MSKCC强制采用短程放疗(SCRT)。
- 多项随机试验显示SCRT与长程放化疗在局部复发、远处复发或总生存上无差异。
核心结论
- 在COVID-19疫情持续且可能延长的背景下,短程放疗是经过充分验证的替代方案,可在资源严重受限时满足更多潜在可治愈患者的需求。
研究设计与样本
- 本文为Memorial Sloan Kettering Cancer Center在COVID-19公共卫生紧急状态下对局部晚期直肠癌实践政策的快速重新评估与叙述性说明。
主要发现
- 疫情前MSKCC常用全程新辅助治疗并强烈偏好长程放化疗,疫情期间则强制采用短程放疗。
- 多项随机试验显示短程放疗与长程放化疗在局部复发、远处复发或总生存上无差异。
- 美国短程放疗采用率一直较低,原因包括对肿瘤降期较少和毒性增加的顾虑。
关键数值与推荐
- 疫情期间MSKCC强制采用短程放疗(SCRT)。
- 多项随机试验显示SCRT与长程放化疗在局部复发、远处复发或总生存上无差异。
临床怎么用
- 在疫情导致资源严重且急性受限时,可考虑采用短程放疗替代长程放化疗以服务更多潜在可治愈患者。
- 需重新评估对短程放疗肿瘤降期较少和毒性增加的顾虑。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The COVID-19 pandemic will consume significant health care resources. Given the concerns for rapidly increasing infection rates in the United States, impending staffing shortages, and the potential for resource reallocation, we rapidly reevaluated our rectal cancer practice policies during this public health emergency. Before the pandemic, we commonly used total neoadjuvant therapy with a strong preference for long-course chemoradiation. In the setting of the ongoing pandemic, we now mandate short-course radiation therapy (SCRT). Despite multiple randomized trials demonstrating no difference in locoregional recurrence, distant recurrence, or overall survival between SCRT and long-course chemoradiation, the adaptation of SCRT in the United States has been low given concerns for less tumor downstaging and increased toxicity. In the setting of the ongoing and likely prolonged COVID-19 pandemic, we feel that these concerns must be reevaluated, because SCRT presents a well-validated alternative that will allow us to meet the needs of a greater number of potentially curable patients at a time when resources are severely and acutely constrained.
引用
- Romesser PB, Wu AJ, Cercek A, et al. Management of Locally Advanced Rectal Cancer During The COVID-19 Pandemic: A Necessary Paradigm Change at Memorial Sloan Kettering Cancer Center. Adv Radiat Oncol. 2020. PMID: 32322758. doi:10.1016/j.adro.2020.04.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。